Van Strydonck, Gerald E. 4

4 · VACCINEX, INC. · Filed May 15, 2023

Form 4

Period: 2023-05-11

Director

Transactions

Award
Stock Option (Right to Buy)
2023-05-11+143,848→ 143,848 total
Exercise: $0.41From: 2024-05-11→ Common Stock (143,848 underlying)

Holdings

Common Stock
67,232
Stock Option (Right to Buy)
Exercise: $13.60Exp: 2027-09-15→ Common Stock (6,396 underlying)
6,396
Stock Option (Right to Buy)
Exercise: $5.26Exp: 2029-03-30→ Common Stock (2,501 underlying)
2,501
Stock Option (Right to Buy)
Exercise: $7.78From: 2020-05-15→ Common Stock (7,718 underlying)
7,718
Stock Option (Right to Buy)
Exercise: $5.52Exp: 2029-06-29→ Common Stock (2,385 underlying)
2,385
Stock Option (Right to Buy)
Exercise: $7.17Exp: 2029-09-27→ Common Stock (1,856 underlying)
1,856
Stock Option (Right to Buy)
Exercise: $4.85Exp: 2029-12-28→ Common Stock (2,737 underlying)
2,737
Stock Option (Right to Buy)
Exercise: $3.95From: 2021-05-14→ Common Stock (15,679 underlying)
15,679
Stock Option (Right to Buy)
Exercise: $2.15From: 2022-05-11→ Common Stock (28,586 underlying)
28,586
Stock Option (Right to Buy)
Exercise: $1.12From: 2023-05-12→ Common Stock (53,254 underlying)
53,254

Footnotes (6)

[F1]Exercisable in full as of the date of this report.
[F2]This option expires on May 14, 2029 or five years following retirement or cessation of services, whichever occurs first.
[F3]This option expires on May 12, 2030 or five years following retirement or cessation of services, whichever occurs first.
[F4]This option expires on May 9, 2031 or five years following retirement or cessation of services, whichever occurs first.
[F5]This option expires on May 9, 2032 or five years following retirement or cessation of services, whichever occurs first.
[F6]This option was granted pursuant to the Company's 2018 Omnibus Incentive Plan in a transaction exempt under Rule 16b-3 and expires on May 8, 2033 or five years following retirement or cessation of services, whichever occurs first.

Documents

1 file